C57BL/6JCya-Tgm6em1/Cya
Common Name:
Tgm6-KO
Product ID:
S-KO-07319
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Tgm6-KO
Strain ID
KOCMP-241636-Tgm6-B6J-VA
Gene Name
Product ID
S-KO-07319
Gene Alias
TGM3L; TGY
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
2
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Tgm6em1/Cya mice (Catalog S-KO-07319) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000028888
NCBI RefSeq
NM_177726
Target Region
Exon 2~7
Size of Effective Region
~6.2 kb
Detailed Document
Overview of Gene Research
TGM6 encodes transglutaminase 6, which catalyzes the covalent crosslinking of proteins via transamination reactions [1]. It has also been identified as a natural antagonist of mammalian TGF-β signaling produced by the murine helminth parasite Heligmosomoides polygyrus, mimicking TGF-β binding to TGFBR2 in fibroblasts [3,5].
TGM6 variants have been associated with spinocerebellar ataxia type 35, but there are doubts about its role as a specific causative gene [4,6]. In Parkinson's disease, 12 low-frequency TGM6 variants were found among 308 patients. Mutant TGM6 plasmids showed lower transglutaminase activity than wild-type, and the protective effects of wild-type TGM6 on cells, such as reducing α-synuclein and enhancing autophagy, were weakened in cells transfected with mutant plasmids [1]. A study questioned the pathogenicity of the TGM6 p.L517W variant in spinocerebellar ataxia 35 as it did not segregate with the phenotype [2]. Genetic analysis also indicated that TGM6 might not be a specific causative gene for spinocerebellar ataxia, as the allele frequencies of its variants did not differ among spinocerebellar ataxia patients and controls, and reported pathogenic variants were found in patients with various neurologic diseases or normal controls [4].
In conclusion, TGM6 has functions in protein cross-linking and modulating TGF-β signaling. Its role in spinocerebellar ataxia type 35 is uncertain, while in Parkinson's disease, TGM6 variants may be related to the disease with potential impacts on cellular protective mechanisms. Further research is needed to clarify its exact functions and roles in these neurological conditions.
References:
1. Chen, Kui, Lu, You, Peng, Fang, Tan, Yan, Zhao, Yan-Xin. . TGM6 variants in Parkinson's disease: clinical findings and functional evidence. In Journal of integrative neuroscience, 19, 51-64. doi:10.31083/j.jin.2020.01.1203. https://pubmed.ncbi.nlm.nih.gov/32259886/
2. Chen, Yanxing, Wu, Dengchang, Luo, Benyan, Zhao, Guohua, Wang, Kang. 2020. TGM6 L517W is not a pathogenic variant for spinocerebellar ataxia type 35. In Neurology. Genetics, 6, e424. doi:10.1212/NXG.0000000000000424. https://pubmed.ncbi.nlm.nih.gov/32426513/
3. White, Stephen E, Schwartze, Tristin A, Mukundan, Ananya, Maizels, Rick M, Hinck, Andrew P. 2023. TGM6, a helminth secretory product, mimics TGF-β binding to TβRII to antagonize TGF-β signaling in fibroblasts. In bioRxiv : the preprint server for biology, , . doi:10.1101/2023.12.22.573140. https://pubmed.ncbi.nlm.nih.gov/38187573/
4. Cheng, Hao-Ling, Dong, Hai-Lin, Liu, De-Shan, Dong, Yi, Wu, Zhi-Ying. 2021. TGM6 might not be a specific causative gene for spinocerebellar ataxia resulting from genetic analysis and functional study. In Gene, 779, 145495. doi:10.1016/j.gene.2021.145495. https://pubmed.ncbi.nlm.nih.gov/33588035/
5. White, Stephen E, Schwartze, Tristin A, Mukundan, Ananya, Maizels, Rick M, Hinck, Andrew P. 2025. TGM6 is a helminth secretory product that mimics TGF-β binding to TGFBR2 to antagonize signaling in fibroblasts. In Nature communications, 16, 1847. doi:10.1038/s41467-025-56954-z. https://pubmed.ncbi.nlm.nih.gov/39984487/
6. Fung, Jasmine L F, Tsang, Mandy H Y, Leung, Gordon K C, Yu, Mullin H C, Chung, Brian H Y. 2019. A significant inflation in TGM6 genetic risk casts doubt in its causation in spinocerebellar ataxia type 35. In Parkinsonism & related disorders, 63, 42-45. doi:10.1016/j.parkreldis.2019.01.013. https://pubmed.ncbi.nlm.nih.gov/30670339/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen